
Hikma Pharmaceuticals Investor Relations Material
Latest events

H1 2025
Hikma Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hikma Pharmaceuticals PLC
Access all reports
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company specializing in the development, manufacturing, and distribution of branded, generic, and injectable medicines. The company serves a wide range of therapeutic areas, including cardiovascular, oncology, pain management, and respiratory diseases. Hikma provides high-quality, affordable medications to hospitals, pharmacies, and wholesalers in global markets. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE (London Stock Exchange).
Key slides for Hikma Pharmaceuticals PLC


H2 2024
Hikma Pharmaceuticals PLC


H1 2025
Hikma Pharmaceuticals PLC
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
HIK
Country
🇬🇧 United Kingdom